My Approach to Recognizing, Diagnosing and Treating Psoriasis in Diverse Skin Tones
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Amy McMichael, professor and chair of the department of dermatology at Wake Forest University School of Medicine, about her approach to recognizing, diagnosing and treating psoriasis in diverse skin tones. Watch as Dr. McMichael shares why psoriasis workups in patients with skin of color should be different. Don’t pro …
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Amy McMichael, professor and chair of the department of dermatology at Wake Forest University School of Medicine, about her approach to recognizing, diagnosing and treating psoriasis in diverse skin tones. Watch as Dr. McMichael shares why psoriasis workups in patients with skin of color should be different. Don’t pro … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. George Han, associate professor of dermatology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Han shares why it’s an exciting time to treat psoriasis, and why the developments of the past year have bolstered the clinician’s armamentarium. Watch and lear … 
Severe Psoriasis Presenting in 3-Year-Old Child With Nail Dystrophy: Response to Biologic Treatment
Danielle Rinck MDa, Elaine Siegfried MDb
aBeth Israel Deaconess Medical Center, Boston, MA | bSaint Louis University School of Medicine, St. Louis, MO
J Drugs Dermatol. 2022;21(8):897-899. doi:10.36849/JDD.6888
A previously healthy 3-year-old boy presented to our Pediatric Derm … 
Next Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed Dr. April Armstrong (Professor of Dermatology and Associate Dean for Clinical Research at the Keck School of Medicine at USC) on applying the psoriasis guidelines established by the American Academy of Dermatology and the National Psor … 
Psoriasis, a chronic inflammatory skin condition, affects about 2% of children. A small subset have isolated nail involvement refractory to topical treatment that can be disabling. The development of targeted biologic agents offers safe, effective options for children with moderate-to-severe skin and nail disease. A few are now Food and Drug Administration (FDA)-approved for children.
INTRODUCTIO … 